AAAAAA

   
Results: 1-25 | 26-50 | 51-67
Results: 1-25/67

Authors: DUPUIS A GACHARD N ALLEGRAUD A PRALORAN V DENIZOT Y
Citation: A. Dupuis et al., PROSTAGLANDIN E-2 STIMULATES THE GROWTH OF HUMAN BLOOD CD34(+) PROGENITORS, PROSTAGLANDINS & OTHER LIPID MEDIATORS, 55(2-3), 1998, pp. 179-186

Authors: NATHAN N DENIZOT Y
Citation: N. Nathan et Y. Denizot, REDUCED PAF-ACETYLHYDROLASE ACTIVITY IS ASSOCIATED WITH POSTINJURY MULTIPLE ORGAN FAILURE - PARTRICK,DAVID,A., MOORE,ERNEST,E., MOORE,FREDERICK,A., BIFFL,WALTER,L., AND BARNETT,CARLTON,C. - SHOCK-7, 170-174, 1997, Shock, 9(3), 1998, pp. 231-231

Authors: DENIZOT Y LORGEOT V CORNU E NATHAN N
Citation: Y. Denizot et al., PLASMA LEUKEMIA INHIBITORY FACTOR, INTERLEUKIN-6 AND SOLUBLE INTERLEUKIN-6 RECEPTOR LEVELS DURING CARDIOPULMONARY BYPASS WITH EXTRACORPOREAL-CIRCULATION, Cytokine, 10(4), 1998, pp. 303-306

Authors: ROUGIER F CORNU E PRALORAN V DENIZOT Y
Citation: F. Rougier et al., IL-6 AND IL-8 PRODUCTION BY HUMAN BONE-MARROW STROMAL CELLS, Cytokine, 10(2), 1998, pp. 93-97

Authors: DENIZOT Y TRIMOREAU F PRALORAN V
Citation: Y. Denizot et al., EFFECTS OF LIPID MEDIATORS ON THE SYNTHESIS OF LEUKEMIA INHIBITORY FACTOR AND INTERLEUKIN-6 BY HUMAN BONE-MARROW STROMAL CELLS, Cytokine (Philadelphia, Pa. Print), 10(10), 1998, pp. 781-785

Authors: DUPUIS F GACHARD N ALLEGRAUD A DULERY C PRALORAN V DENIZOT Y
Citation: F. Dupuis et al., EFFECT OF PLATELET-ACTIVATING-FACTOR ON THE GROWTH OF HUMAN ERYTHROIDAND MYELOID CD34(+) PROGENITORS, Mediators of inflammation, 7(2), 1998, pp. 99-103

Authors: NATHAN N DENIZOT Y
Citation: N. Nathan et Y. Denizot, ANTIINFLAMMATORY CYTOKINES (IL-4, IL-10, IL-13) IN PLASMA DURING MESENTERIC INFARCTION, Mediators of inflammation, 7(2), 1998, pp. 119-119

Authors: DESPLAT V DUPUIS F TRIMOREAU F DULERY C PRALORAN V DENIZOT Y
Citation: V. Desplat et al., EFFECTS OF LIPOXYGENASE METABOLITES OF ARACHIDONIC-ACID ON THE GROWTHOF HUMAN MONONUCLEAR MARROW-CELLS AND MARROW STROMAL CELL-CULTURES, Mediators of inflammation, 7(1), 1998, pp. 31-33

Authors: ROUGIER F DENIZOT Y
Citation: F. Rougier et Y. Denizot, PLATELET-ACTIVATING-FACTOR AND THE GROWTH OF FIBROBLASTS, Molecular carcinogenesis, 22(4), 1998, pp. 221-221

Authors: DENIZOT Y DULERY C TRIMOREAU F DESPLAT V PRALORAN V
Citation: Y. Denizot et al., ARACHIDONIC-ACID AND HUMAN BONE-MARROW STROMAL CELLS, Biochimica et biophysica acta. Molecular cell research, 1402(2), 1998, pp. 209-215

Authors: LORGEOT V TRIMOREAU F GACHARD N PRALORAN V DENIZOT Y
Citation: V. Lorgeot et al., LEUKEMIA INHIBITORY FACTOR CONCENTRATIONS IN THE BONE-MARROW PLASMA OF HEALTHY-SUBJECTS AND PATIENTS WITH HEMATOLOGIC MALIGNANCIES, European cytokine network, 8(1), 1997, pp. 57-59

Authors: FIXE P ROUGIER E OSTYN E GACHARD N FAUCHER JL PRALORAN V DENIZOT Y
Citation: P. Fixe et al., SPONTANEOUS AND INDUCIBLE PRODUCTION OF MACROPHAGE-COLONY-STIMULATINGFACTOR BY HUMAN BONE-MARROW STOMAL CELLS, European cytokine network, 8(1), 1997, pp. 91-95

Authors: LORGEOT V ROUGIER F FIXE P CORNU E PRALORAN V DENIZOT Y
Citation: V. Lorgeot et al., SPONTANEOUS AND INDUCIBLE PRODUCTION OF LEUKEMIA INHIBITORY FACTOR BYHUMAN BONE-MARROW STROMAL CELLS, Cytokine, 9(10), 1997, pp. 754-758

Authors: ROUGIER F CORNU E GACHARD N PRALORAN V DENIZOT Y
Citation: F. Rougier et al., TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) STIMULATES THE GROWTH OF HUMAN BONE-MARROW STROMAL CELLS, Mediators of inflammation, 6(3), 1997, pp. 233-235

Authors: VERGNE P PRALORAN V TREVES R DENIZOT Y
Citation: P. Vergne et al., DECREASED LEVELS OF SERUM PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE IN PATIENTS WITH RHEUMATIC DISEASES, Mediators of inflammation, 6(3), 1997, pp. 241-242

Authors: NATHAN N DENIZOT Y FEISS P
Citation: N. Nathan et al., EICOSANOID AND CYTOKINE LEVELS IN PLASMA OF PATIENTS DURING MESENTERIC INFARCTION, Mediators of inflammation, 6(1), 1997, pp. 75-77

Authors: DUPUIS F DESPLAT V PRALORAN V DENIZOT Y
Citation: F. Dupuis et al., EFFECTS OF LIPIDIC MEDIATORS ON THE GROWTH OF HUMAN MYELOID AND ERYTHROID MARROW PROGENITORS, Journal of lipid mediators and cell signalling, 16(3), 1997, pp. 117-125

Authors: ROUGIER F DUPUIS F CORNU E DULERY C PRALORAN V DENIZOT Y
Citation: F. Rougier et al., PLATELET-ACTIVATING-FACTOR AND ANTAGONISTS MODULATE DNA-SYNTHESIS IN HUMAN BONE-MARROW STROMAL CELL-CULTURES, Journal of lipid mediators and cell signalling, 16(3), 1997, pp. 147-153

Authors: DENIZOT Y ROUGIER F DUPUIS F TRIMOREAU F DULERY C LASKAR M PRALORAN V
Citation: Y. Denizot et al., PRESENCE AND METABOLISM OF LYSO-PLATELET-ACTIVATING-FACTOR IN HUMAN BONE-MARROW, Journal of lipid mediators and cell signalling, 16(1), 1997, pp. 53-62

Authors: DUPUIS F ROUGIER F TRIMOREAU F OSTYN E DULERY C PRALORAN V DENIZOT Y
Citation: F. Dupuis et al., PRODUCTION AND METABOLISM OF PLATELET-ACTIVATING-FACTOR BY HUMAN BONE-MARROW CELLS, Research in immunology, 148(2), 1997, pp. 119-126

Authors: LORGEOT V PRALORAN V TURLURE P DENIZOT Y
Citation: V. Lorgeot et al., CONCENTRATIONS OF SERUM LEUKEMIA INHIBITORY FACTOR (LIF) IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES, Leukemia, 11(2), 1997, pp. 311-312

Authors: DUPUIS F LEVASSEUR S JEANLOUIS F DULERY C PRALORAN V DENIZOT Y MICHEL L
Citation: F. Dupuis et al., PRODUCTION, METABOLISM AND EFFECT OF PLATELET-ACTIVATING-FACTOR ON THE GROWTH OF THE HUMAN K562 ERYTHROID CELL-LINE, Biochimica et biophysica acta. Molecular cell research, 1359(3), 1997, pp. 241-249

Authors: TRIMOREAU F VERGER C PRALORAN V DENIZOT Y
Citation: F. Trimoreau et al., NO SEX-RELATED DIFFERENCE IN THE MYELOID ERYTHROID RATIO IN MORPHOLOGICALLY NORMAL BONE-MARROW ASPIRATES/, British Journal of Haematology, 97(3), 1997, pp. 687-687

Authors: NATHAN N DENIZOT Y CORNU E JAUBERTEAU MO CHAUVREAU C FEISS P
Citation: N. Nathan et al., CYTOKINE AND LIPID MEDIATOR BLOOD-CONCENTRATIONS AFTER CORONARY-ARTERY SURGERY, Anesthesia and analgesia, 85(6), 1997, pp. 1240-1246

Authors: ROUGIER F DUPUIS F DENIZOT Y
Citation: F. Rougier et al., HUMAN BONE-MARROW FIBROBLASTS - AN OVERVIEW OF THEIR CHARACTERIZATION, PROLIFERATION AND INFLAMMATORY MEDIATOR PRODUCTION, HEM CELL TH, 38(3), 1996, pp. 241-246
Risultati: 1-25 | 26-50 | 51-67